PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethyl acetate extracts of S. gummiferum subsp. gummiferum and subsp. corymbosum showed 35.1% to 36.9% inhibition of carrageenan-induced hind paw edema in vivo [PMID:16226417].
Ethyl acetate extracts and specific 3'-acetoxy coumarin derivatives showed significant inhibitory activity against p-benzoquinone-induced writhing models in mice [PMID:16226417, PMID:19323267].
Methanolic and water extracts of S. gummiferum demonstrated total antioxidant capacity (0.66-1.18 mM TE/g) and radical scavenging activity (DPPH: 5.51-11.45 mg TE/g; ABTS: 43.46-51.91 mg TE/g) [PMID:34679647].
Evidence summary
PubMed sources
- 1.PMID: 16226417 (2006) — Anti-inflammatory and antinociceptive activities of Seseli L. species (Apiaceae) growing in Turkey. · Journal of ethnopharmacology
- 2.PMID: 26491389 (2015) — A new subspecies of Seseli gummiferum (Apiaceae) from Ilgaz Mountain National Park, northern Turkey. · PhytoKeys
- 3.PMID: 32454780 (2020) — Evaluation of the Antioxidant Potency of Seseli L. Species (Apiaceae). · Turkish journal of pharmaceutical sciences
- 4.PMID: 34679647 (2021) — Comprehensive Biological and Chemical Evaluation of Two Seseli Species (S. gummiferum and S. transcaucasicum). · Antioxidants (Basel, Switzerland)
- 5.PMID: 26761723 (2016) — Anti-inflammatory effect of corymbocoumarin from Seseli gummiferum subsp. corymbosum through suppression of NF-κB signaling pathway and induction of HO-1 expression in LPS-stimulated RAW 264.7 cells.